ChemicalBook >> CAS DataBase List >>Tipifarnib

Tipifarnib

CAS No.
192185-72-1
Chemical Name:
Tipifarnib
Synonyms
R115777;CS-2330;IND 58359;Zarnestra;ipifarnib;TIPIFARNIB;(R)-(+)-R 115777;Tipifarnib(R115777);TIPIFARNIB ZARNESTRA;Tipifarnib USP/EP/BP
CBNumber:
CB61011759
Molecular Formula:
C27H22Cl2N4O
Molecular Weight:
489.4
MDL Number:
MFCD07772347
MOL File:
192185-72-1.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:19

Tipifarnib Properties

Melting point 211-213°C (dec.)
Boiling point 681.7±55.0 °C(Predicted)
Density 1.33±0.1 g/cm3(Predicted)
storage temp. -20°C
solubility Chloroform (Slightly), Methanol (Slightly)
pka 7.20±0.10(Predicted)
form powder
color white to beige
optical activity [α]/D 17 to 24°, c = 1 in methanol
NCI Dictionary of Cancer Terms R115777; tipifarnib; Zarnestra
FDA UNII MAT637500A
NCI Drug Dictionary tipifarnib

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P305+P351+P338
HS Code  2933790090

Tipifarnib price More Price(47)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML1668 Tipifarnib ≥98% (HPLC) 192185-72-1 5MG $131 2023-06-20 Buy
Sigma-Aldrich SML1668 Tipifarnib ≥98% (HPLC) 192185-72-1 25MG $530 2023-06-20 Buy
Cayman Chemical 11747 Tipifarnib ≥98% 192185-72-1 1mg $44 2024-03-01 Buy
Cayman Chemical 11747 Tipifarnib ≥98% 192185-72-1 5mg $118 2024-03-01 Buy
Cayman Chemical 11747 Tipifarnib ≥98% 192185-72-1 10mg $214 2024-03-01 Buy
Product number Packaging Price Buy
SML1668 5MG $131 Buy
SML1668 25MG $530 Buy
11747 1mg $44 Buy
11747 5mg $118 Buy
11747 10mg $214 Buy

Tipifarnib Chemical Properties,Uses,Production

Chemical Properties

Off-White to Pale Beige Solid

Uses

A farnesyltransferase inhibitor. Sensitizes human multiple myeloma cell to proteasome inhibition by blocking degradation of bortezomib(B675700)-induced aggresomes. Also shown to inhibit the growth of myeloid leukemia cell lines and primary leukemia cells by inducing apoptosis and cell-cycle blockage when combined with rapamycin(R124000).

Definition

ChEBI: Tipifarnib is a quinolone that is 1-methylquinolin-2-one which carries a 3-chlorophenyl and an amino(4-chlorophenyl)(1-methyl-imidazol-5-yl)methyl groups at the 4 and 6 positions, respectively (the R-isomer). It has a role as an antineoplastic agent, an EC 2.5.1.58 (protein farnesyltransferase) inhibitor and an apoptosis inducer. It is a quinolone, a member of monochlorobenzenes, a member of imidazoles and a primary amino compound.

General Description

Pre-clinical studies show that tipifarnib has antiproliferative effects on pancreatic cancer cell lines at clinically relevant concentrations (concentration that inhibits 50% growth [IC50] from 9.5 to 500?nmol/L). It also exhibits marked growth retardation and antiangiogenic effects in a pancreatic cancer xenograft model.

Biological Activity

tipifarnib (also known as zarnestra or r115777), an orally bioavailable quinolone analog of imidazole heterocyclics, is a potent and specific nonpeptidomimetic competitive inhibitor of farnesyltransferase (ftase), an enezyme mediating post-translational farnesylation of multiple protein substrates involved in tumor cell proliferation. it has demonstrated inhibition of growth and proliferation of a broad range of human tumor models (either wild-type or mutated ras) via cytostatic rather than cytotoxic activity both in vitro and in vivo. it cell-type dependently induces apoptosis in some neoplastic cell lineages other than acute myeloid leukemia (aml), including multiple myeloma (mm) cell lines and mm cultures from patients.p.k. epling-burnett and thomas p. loughran jr. suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib. expert opin investig drugs. 2010; 19(5): 689-698jean-pierre armand, alan k. burnett, johannes drach, jean-luc harousseau, bob lowenberg and jesus san miguel. the emerging role of targeted therapy for hematologic malignancies: update on bortezomib and tipifarnib. the oncologist 2007, 12:281-290elzbieta izbicka, david campos, gilbert carrizales and amita patnaik. biomarkers of anticancer activity of r115777 (tipifarnib, zarnestra) in human breast cancer models in vitro. anticancer research 2005; 25: 3215-3224

Biochem/physiol Actions

Tipifarnib (R115777) is an orally active and potent farnesyltransferase (FTase) inhibitor that exhibits potent anti-tumorigenic effects. Tipifarnib mechanism of action is not fully understand.

target

FTase

Tipifarnib Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 154)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32715 60
career henan chemical co
+86-0371-86658258 15093356674; sales@coreychem.com China 29914 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873 sales@chemdad.com China 39916 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49391 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 27435 58
Chemia Biotechnology(Shanghai) Co., Ltd
+8613816753574 info@chemia-pharm.com CHINA 311 58
Finetech Industry Limited
+86-27-87465837 +8618971612321 info@finetechnology-ind.com China 9626 58
Hefei Hirisun Pharmatech Co., Ltd
+8615056975894 shawn@hirisunpharm.com CHINA 9923 58

View Lastest Price from Tipifarnib manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Tipifarnib pictures 2019-07-06 Tipifarnib
192185-72-1
US $2.00 / kg 1kg 99% 100kg Career Henan Chemical Co
  • Tipifarnib pictures
  • Tipifarnib
    192185-72-1
  • US $2.00 / kg
  • 99%
  • Career Henan Chemical Co

Tipifarnib Spectrum

TIPIFARNIB TIPIFARNIB ZARNESTRA (R)-6-(Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone Zarnestra (R)-(+)-R 115777 6-[(R)-AMino(4-chlorophenyl)(1-Methyl-1H-iMidazol-5-yl)Methyl]-4-(3-chlorophenyl)-1-Methyl-2(1H)-quinolinone Tipifarnib(Zarnestra,NSC-702818, R-115777) IND 58359 R115777 Tipifarnib(R115777) (R)-6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methylquinolin-2(1H)-one Tipifarnib (IND 58359 ipifarnib CS-2330 ZARNESTRA; IND 58359; R115777; IND-58359; IND58359; R-115777; R 115777 Tipifarnib (Zarnestra) IND 58359, R115777 2(1H)-Quinolinone, 6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl- Tipifarnib USP/EP/BP 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one 192185-72-1 192185-71-4 Inhibitors Amines Aromatics Heterocycles Intermediates & Fine Chemicals Pharmaceuticals Tyrosine Kinase Inhibitors Inhibitor Antineoplastic